Custom Premix Selecting "Custom Premix" option means that all of the beads you have chosen will be premixed in manufacturing before the kit is sent to you.
Recombinant, human galectin-3 expressed in E. coli. Galectin-3 is a member of the β-galactoside-binding animal lectins. It has been implicated to be involved in various immunological processes, pre-mRNA splicing, cell adhesion, and tumor invasion. Levels of galectin-3 have been reported to be elevated in several metastatic cancers.
Catalogue Number
345830
Brand Family
Calbiochem®
Synonyms
CBP30, CBP35, εBP, L-29, L-34, Mac-2
References
References
Legendre, H., et al. 2003. Mod. Pathol.16, 491. Maeda, M., et al. 2003. J. Biol. Chem.278, 18938. Stock, M., et al. 2003. J. Biol. Chem.278, 17360. Hirabayashi, J., et al. 2002. Biochim. Biophys. Acta1572, 232. Iurisci, I., et al. 2000. Clin. Cancer Res.6, 1389. Oda, Y., et al. 1991. Gene99, 279.
Following reconstitution refrigerate (4°C). Stock solutions containing lactose are stable for up to 6 months at 4°C. Following dialysis and removal of lactose, stock solutions are stable for up to 4 days at 4°C.
Legendre, H., et al. 2003. Mod. Pathol.16, 491. Maeda, M., et al. 2003. J. Biol. Chem.278, 18938. Stock, M., et al. 2003. J. Biol. Chem.278, 17360. Hirabayashi, J., et al. 2002. Biochim. Biophys. Acta1572, 232. Iurisci, I., et al. 2000. Clin. Cancer Res.6, 1389. Oda, Y., et al. 1991. Gene99, 279.
数据表
Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.
Revision
30-June-2008 RFH
Synonyms
CBP30, CBP35, εBP, L-29, L-34, Mac-2
Description
Recombinant, human galectin-3 expressed in and purified from E. coli. Galectin-3 is a member of the β-galactoside-binding animal lectins. It has been implicated to be involved in various immunological processes, pre-mRNA splicing, cell adhesion, and tumor invasion. Levels of galectin-3 have been reported to be elevated in several metastatic cancers.
Form
Lyophilized
Formulation
Lyophilized from diH₂O.
Purity
≥95% by SDS-PAGE
Contaminants
Endotoxin: ≤1.0 EU/µg galectin-3
Solubility
Reconstitute in sterile PBS. For use in carbohydrate binding studies, lactose should be removed by dialysis.
Storage
Avoid freeze/thaw
-20°C
Do Not Freeze
Ok to freeze
Special Instructions
Following reconstitution refrigerate (4°C). Stock solutions containing lactose are stable for up to 6 months at 4°C. Following dialysis and removal of lactose, stock solutions are stable for up to 4 days at 4°C.
Toxicity
Standard Handling
References
Legendre, H., et al. 2003. Mod. Pathol.16, 491. Maeda, M., et al. 2003. J. Biol. Chem.278, 18938. Stock, M., et al. 2003. J. Biol. Chem.278, 17360. Hirabayashi, J., et al. 2002. Biochim. Biophys. Acta1572, 232. Iurisci, I., et al. 2000. Clin. Cancer Res.6, 1389. Oda, Y., et al. 1991. Gene99, 279.
